STOCK TITAN

[8-K] Aclaris Therapeutics, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

UK-based M&G Plc, through certain wholly owned subsidiaries, has filed a Schedule 13G indicating it now beneficially owns 1,835,681 shares of Spirit Aviation Holdings, Inc. common stock (CUSIP 84863V101). The position represents 7.09 % of the outstanding shares and is held with sole voting and dispositive power; no shares are held jointly. The filing is made under Rule 13d-1(b), classifying M&G as a parent holding company (HC). The shares are held in the ordinary course of business for investment vehicles managed by M&G affiliates, and the filer expressly disclaims any intent to influence control of the issuer. Signature by Regulatory Reporting Technical Manager Tamara Postoj is dated 08 Aug 2025.

M&G Plc, con sede nel Regno Unito, tramite alcune filiali interamente controllate, ha depositato un Schedule 13G indicando di detenere ora beneficiariamente 1.835.681 azioni ordinarie di Spirit Aviation Holdings, Inc. (CUSIP 84863V101). La posizione rappresenta il 7,09% delle azioni in circolazione ed è detenuta con pieno potere di voto e di disposizione; nessuna azione è detenuta congiuntamente. La comunicazione è stata effettuata ai sensi della Regola 13d-1(b), classificando M&G come società madre (HC). Le azioni sono detenute nell’ordinaria gestione degli investimenti per veicoli gestiti da affiliati di M&G, e il dichiarante esclude espressamente qualsiasi intento di influenzare il controllo dell’emittente. La firma della Responsabile Tecnica per la Segnalazione Regolamentare, Tamara Postoj, è datata 08 agosto 2025.

M&G Plc, con sede en el Reino Unido, a través de ciertas subsidiarias de propiedad total, ha presentado un Schedule 13G indicando que ahora posee beneficiosamente 1,835,681 acciones ordinarias de Spirit Aviation Holdings, Inc. (CUSIP 84863V101). La posición representa el 7,09% de las acciones en circulación y se mantiene con poder exclusivo de voto y disposición; no hay acciones en propiedad conjunta. La presentación se realiza bajo la Regla 13d-1(b), clasificando a M&G como una compañía matriz (HC). Las acciones se mantienen en el curso ordinario de negocios para vehículos de inversión gestionados por afiliados de M&G, y el declarante niega expresamente cualquier intención de influir en el control del emisor. La firma de la Gerente Técnica de Reportes Regulatorios, Tamara Postoj, está fechada el 08 de agosto de 2025.

영국에 본사를 둔 M&G Plc는 전액 출자 자회사를 통해 Spirit Aviation Holdings, Inc. 보통주(CUSIP 84863V101) 1,835,681주를 실질적으로 보유하고 있음을 나타내는 Schedule 13G를 제출했습니다. 이 지분은 발행 주식의 7.09%에 해당하며, 단독 의결권 및 처분권을 가지고 있으며 공동 보유 주식은 없습니다. 이 제출은 규칙 13d-1(b)에 따라 이루어졌으며, M&G를 모회사(HC)로 분류합니다. 주식은 M&G 계열사가 관리하는 투자 기구의 정상적인 사업 과정에서 보유하고 있으며, 제출자는 발행사의 경영권에 영향을 미칠 의도가 없음을 명시적으로 부인합니다. 규제 보고 기술 관리자 타마라 포스토이(Tamara Postoj)의 서명은 2025년 8월 8일자로 되어 있습니다.

M&G Plc, basé au Royaume-Uni, via certaines filiales en propriété exclusive, a déposé un Schedule 13G indiquant qu'il détient désormais bénéficiairement 1 835 681 actions ordinaires de Spirit Aviation Holdings, Inc. (CUSIP 84863V101). Cette position représente 7,09 % des actions en circulation et est détenue avec le pouvoir exclusif de vote et de disposition ; aucune action n'est détenue conjointement. Le dépôt est effectué conformément à la règle 13d-1(b), classant M&G comme une société mère (HC). Les actions sont détenues dans le cours normal des affaires pour des véhicules d'investissement gérés par des affiliés de M&G, et le déposant décline expressément toute intention d'influencer le contrôle de l'émetteur. La signature de la Responsable Technique des Rapports Réglementaires, Tamara Postoj, est datée du 8 août 2025.

Das im Vereinigten Königreich ansässige Unternehmen M&G Plc hat über bestimmte hundertprozentige Tochtergesellschaften eine Schedule 13G eingereicht, die angibt, dass es nun wirtschaftlich 1.835.681 Aktien der Spirit Aviation Holdings, Inc. Stammaktien (CUSIP 84863V101) besitzt. Die Position entspricht 7,09 % der ausstehenden Aktien und wird mit alleinigem Stimm- und Verfügungsrecht gehalten; keine Aktien werden gemeinsam gehalten. Die Einreichung erfolgt gemäß Regel 13d-1(b) und klassifiziert M&G als Muttergesellschaft (HC). Die Aktien werden im normalen Geschäftsverlauf für von M&G-Tochtergesellschaften verwaltete Investmentvehikel gehalten, und der Einreicher weist ausdrücklich jede Absicht zurück, die Kontrolle über den Emittenten zu beeinflussen. Die Unterschrift der Regulatory Reporting Technical Managerin Tamara Postoj datiert vom 08. August 2025.

Positive
  • Institutional confidence: A well-known UK asset manager now controls 7.09 % of outstanding shares, potentially supporting trading liquidity and market visibility.
Negative
  • None.

Insights

TL;DR: M&G declares a 7.1 % passive stake in Spirit Aviation; neutral but signals institutional interest.

The filing shows M&G Plc has crossed the 5 % reporting threshold with a 1.84 M-share position, giving it sole voting and disposal rights. Because the Schedule 13G is filed under Rule 13d-1(b) and includes a certification of passive intent, the stake appears non-activist. While added institutional ownership can support liquidity and perceived confidence, there is no immediate governance or strategic impact disclosed. Overall, the development is informational rather than transformative for valuation or control dynamics.

M&G Plc, con sede nel Regno Unito, tramite alcune filiali interamente controllate, ha depositato un Schedule 13G indicando di detenere ora beneficiariamente 1.835.681 azioni ordinarie di Spirit Aviation Holdings, Inc. (CUSIP 84863V101). La posizione rappresenta il 7,09% delle azioni in circolazione ed è detenuta con pieno potere di voto e di disposizione; nessuna azione è detenuta congiuntamente. La comunicazione è stata effettuata ai sensi della Regola 13d-1(b), classificando M&G come società madre (HC). Le azioni sono detenute nell’ordinaria gestione degli investimenti per veicoli gestiti da affiliati di M&G, e il dichiarante esclude espressamente qualsiasi intento di influenzare il controllo dell’emittente. La firma della Responsabile Tecnica per la Segnalazione Regolamentare, Tamara Postoj, è datata 08 agosto 2025.

M&G Plc, con sede en el Reino Unido, a través de ciertas subsidiarias de propiedad total, ha presentado un Schedule 13G indicando que ahora posee beneficiosamente 1,835,681 acciones ordinarias de Spirit Aviation Holdings, Inc. (CUSIP 84863V101). La posición representa el 7,09% de las acciones en circulación y se mantiene con poder exclusivo de voto y disposición; no hay acciones en propiedad conjunta. La presentación se realiza bajo la Regla 13d-1(b), clasificando a M&G como una compañía matriz (HC). Las acciones se mantienen en el curso ordinario de negocios para vehículos de inversión gestionados por afiliados de M&G, y el declarante niega expresamente cualquier intención de influir en el control del emisor. La firma de la Gerente Técnica de Reportes Regulatorios, Tamara Postoj, está fechada el 08 de agosto de 2025.

영국에 본사를 둔 M&G Plc는 전액 출자 자회사를 통해 Spirit Aviation Holdings, Inc. 보통주(CUSIP 84863V101) 1,835,681주를 실질적으로 보유하고 있음을 나타내는 Schedule 13G를 제출했습니다. 이 지분은 발행 주식의 7.09%에 해당하며, 단독 의결권 및 처분권을 가지고 있으며 공동 보유 주식은 없습니다. 이 제출은 규칙 13d-1(b)에 따라 이루어졌으며, M&G를 모회사(HC)로 분류합니다. 주식은 M&G 계열사가 관리하는 투자 기구의 정상적인 사업 과정에서 보유하고 있으며, 제출자는 발행사의 경영권에 영향을 미칠 의도가 없음을 명시적으로 부인합니다. 규제 보고 기술 관리자 타마라 포스토이(Tamara Postoj)의 서명은 2025년 8월 8일자로 되어 있습니다.

M&G Plc, basé au Royaume-Uni, via certaines filiales en propriété exclusive, a déposé un Schedule 13G indiquant qu'il détient désormais bénéficiairement 1 835 681 actions ordinaires de Spirit Aviation Holdings, Inc. (CUSIP 84863V101). Cette position représente 7,09 % des actions en circulation et est détenue avec le pouvoir exclusif de vote et de disposition ; aucune action n'est détenue conjointement. Le dépôt est effectué conformément à la règle 13d-1(b), classant M&G comme une société mère (HC). Les actions sont détenues dans le cours normal des affaires pour des véhicules d'investissement gérés par des affiliés de M&G, et le déposant décline expressément toute intention d'influencer le contrôle de l'émetteur. La signature de la Responsable Technique des Rapports Réglementaires, Tamara Postoj, est datée du 8 août 2025.

Das im Vereinigten Königreich ansässige Unternehmen M&G Plc hat über bestimmte hundertprozentige Tochtergesellschaften eine Schedule 13G eingereicht, die angibt, dass es nun wirtschaftlich 1.835.681 Aktien der Spirit Aviation Holdings, Inc. Stammaktien (CUSIP 84863V101) besitzt. Die Position entspricht 7,09 % der ausstehenden Aktien und wird mit alleinigem Stimm- und Verfügungsrecht gehalten; keine Aktien werden gemeinsam gehalten. Die Einreichung erfolgt gemäß Regel 13d-1(b) und klassifiziert M&G als Muttergesellschaft (HC). Die Aktien werden im normalen Geschäftsverlauf für von M&G-Tochtergesellschaften verwaltete Investmentvehikel gehalten, und der Einreicher weist ausdrücklich jede Absicht zurück, die Kontrolle über den Emittenten zu beeinflussen. Die Unterschrift der Regulatory Reporting Technical Managerin Tamara Postoj datiert vom 08. August 2025.

0001557746false00015577462025-08-072025-08-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 7, 2025

Aclaris Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-37581

46-0571712

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

701 Lee Road, Suite 103

Wayne, PA 19087

(Address of principal executive offices, including zip code)

(484) 324-7933

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: 

 

 

 

 

 

Title of Each Class:

 

Trading Symbol(s)

 

Name of Each Exchange on which Registered

Common Stock, $0.00001 par value

 

ACRS

 

The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02 Results of Operations and Financial Condition.

On August 7, 2025, Aclaris Therapeutics, Inc. (the “Registrant”) issued a press release announcing its financial results for the quarter and six months ended June 30, 2025. A copy of this press release is furnished herewith as Exhibit 99.1 to this Current Report.

In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Registrant’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit

 

Number

Exhibit Description

99.1

Press Release, dated August 7, 2025.

104

The cover page from Aclaris Therapeutics, Inc.’s Form 8-K filed on August 7, 2025, formatted in Inline XBRL.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

ACLARIS THERAPEUTICS, INC.

Date: August 7, 2025

By:  

/s/ Kevin Balthaser

Kevin Balthaser
Chief Financial Officer

3

FAQ

How many Spirit Aviation shares does M&G Plc own?

M&G reports beneficial ownership of 1,835,681 common shares.

What percentage of Spirit Aviation's outstanding stock does this represent?

The stake equals 7.09 % of the issuer’s outstanding common shares.

Does M&G have shared voting or dispositive power?

No. The filing shows sole voting and dispositive power; shared power is zero.

Is this an activist position?

The Schedule 13G is filed under Rule 13d-1(b) with a passive intent certification, indicating non-activist ownership.

Why did M&G have to file a Schedule 13G?

SEC rules require any person owning over 5 % of a U.S. company’s class of shares to file within 45 days; M&G crossed that threshold.
Aclaris Therapeutics Inc

NASDAQ:ACRS

ACRS Rankings

ACRS Latest News

ACRS Latest SEC Filings

ACRS Stock Data

167.84M
105.37M
2.69%
87.79%
7.18%
Biotechnology
Pharmaceutical Preparations
Link
United States
WAYNE